GTES Q1 2026 Earnings EPS Surpasses Estimates by 47 CGON Q1 2026 Earnings EPS Miss as ClinicalStage Oncology Firm Reports No Revenue Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Operations Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up MITP Q1 2026 Earnings EPS Beats Estimates Amid Steady Mortgage Operations SOBR Q3 2025 Earnings Net Loss of 144 per Share Amidst Operational Focus